Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Study of Capecitabine in Metastatic Non-clear Cell Renal Cell Carcinoma Patients

NCT01182142 is registered in ClinicalTrials.gov with Kidney Cancer Research Bureau as lead sponsor.

NCT NCT01182142
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01182142 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Study of Capecitabine in Metastatic Non-clear Cell Renal Cell Carcinoma Patients
Lead sponsor
Kidney Cancer Research Bureau
Phase
Phase 2
Overall status
Completed
Start date
September 30, 2007
Completion date
August 31, 2010
Enrollment
51 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic renal cell carcinoma